Mylan

Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Endpoints
Biogen
Tecfidera
Mylan
generics
Flag link:
Mylan and Pfizer roll out tricolor branding for their giant generics combo, Viatris
Mylan and Pfizer roll out tricolor branding for their giant generics combo, Viatris
Fierce Pharma
Mylan
Pfizer
Upjohn
M&A
generics
Viatris
branding
Flag link:
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
Flag link:
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Biogen
Tecfidera
Mylan
patents
generics
MS
multiple sclerosis
Flag link:
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Fierce Pharma
Biogen
Mylan
Tecfidera
patents
MS
multiple sclerosis
Flag link:
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Motley Fool
FDA
Mylan
Biocon
Semglee
Sanofi
insulin
Lantus
diabetes
Flag link:
What's Behind Mylan's Mixed Q1 Results
What's Behind Mylan's Mixed Q1 Results
Motley Fool
Mylan
Pfizer
Upjohn
M&A
Viatris
earnings
Flag link:
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger
Beckers Hospital Review
Mylan
Robert Coury
Upjohn
generics
M&A
COVID-19
pandemic
Flag link:
Mylan prepares hydroxychloroquine giveaways after production ramp-up
Mylan prepares hydroxychloroquine giveaways after production ramp-up
Fierce Pharma
Mylan
hydroxychloroquine
COVID-19
drug manufacturing
Flag link:
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Fierce Pharma
Biocon
insulin
diabetes
Lantus
Mylan
drug manufacturing
Flag link:
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Mylan, Pfizer offer undisclosed concessions as part of EU merger review
Fierce Pharma
Mylan
Pfizer
Upjohn
Europe
M&A
Flag link:
FDA warns of premature EpiPen auto-injector activations
FDA warns of premature EpiPen auto-injector activations
Fierce Biotech
FDA
EpiPens
Mylan
Flag link:
Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
Pfizer, Mylan say COVID-19 delays will postpone their Viatris merger
Fierce Pharma
COVID-19
Pfizer
Mylan
Viatris
M&A
Flag link:
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
All the Drugs Proving Anecdotally Effective Against COVID-19, and the Companies That Make Them
Motley Fool
COVID-19
Gilead Sciences
Mylan
Bayer
chloroquine
hydroxychloroquine
Fujifilm
Avigan
Kevzara
Actemra
Regeneron
Sanofi
Roche
Flag link:
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Teva and Mylan to jumpstart production of old malaria drug to fight the novel coronavirus
Stat
Teva Pharmaceutical
Mylan
malaria
hydroxychloroquine
COVID-19
Flag link:
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Flag link:
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Motley Fool
Biogen
Mylan
Alzheimer's disease
patents
Tecfidera
MS
multiple sclerosis
Vumerity
Flag link:
Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis
Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis
BioSpace
MS
multiple sclerosis
Biogen
Sanofi
Active Biotech
Mylan
Novartis
Adamas
Flag link:
Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Fierce Pharma
Biogen
patents
Tecfidera
Mylan
multiple sclerosis
MS
Flag link:
Pfizer is bulking up its Mylan-Upjohn spinoff but investors may not reap rewards: analysts
Pfizer is bulking up its Mylan-Upjohn spinoff but investors may not reap rewards: analysts
Fierce Pharma
Pfizer
Mylan
Upjohn
Viatris
China
Flag link:

Pages